ABT vs COO
Abbott Laboratories vs Cooper Companies (The) — AI-powered side-by-side comparison
ABT
Abbott Laboratories
66
Buy
VS
COO
Cooper Companies (The)
68
Buy
| Metric | ABT | COO |
|---|
| AI Score |
66
|
68
|
| Price |
$116.22
|
$73.45
|
| P/E Ratio |
37.51×
|
64.24×
|
| ROE |
12.5%
|
4.6%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
56.8%
|
64.4%
|
| Debt / Equity |
0.64×
|
0.30×
|
| Dividend Yield |
2.1%
|
0.0%
|
| RSI (14) |
84.7
|
54.1
|
| Beta |
0.581
|
0.823
|
| Expected Upside |
+0.1%
|
+0.1%
|
AI Committee View
Current Innellis committee reasoning for ABT versus COO.
COO leads by 2 points.
COO scores 68/100 (Buy) versus ABT at 66/100 (Buy).
ABT Committee View
50% agreement
4 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- RSI at 85 is in overbought territory — Technical
- Price trading above the upper Bollinger Band -- stretched — Technical
- Weekly RSI at 83 -- overbought on the larger timeframe too — Technical
COO Committee View
80% agreement
5 analysts
The primary driver is 4 consecutive earnings beats -- consistent execution. The main limiting factor is macd histogram negative -- bearish momentum. The committee is constructive but not yet at full conviction.
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical